Researchers examined blood–brain barrier disruption, by assessing brain-derived neurotropic factor, neuron-specific enolase levels, and gut-blood barrier disruption by trimethylamine N-oxide in chronic kidney disease patients.
[Scientific Reports]
6445212
BBBBBBBB
items
1
apa
0
default
asc
1
172937
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
